MCB 10-Q Details $50M Nine-Month Charge-Offs and ACL Cut to $64.2M
MCB sits 48% above its 52-week low of $64.66.
Summary
Metropolitan Bank's Q3 10-Q backs up the $32.4 million ($2.58 diluted EPS) quarter already reported October 20, disclosing $50.0 million of nine-month net charge-offs and an allowance cut to $64.2 million, or 0.85% of loans.
Key Events · Earnings and Guidance · MCB
-
Q3 Earnings Detail Confirms $32.4M
Net income of $32.4 million, or $2.58 per diluted share, for Q3 2026 versus $7.1 million ($0.67) a year earlier; net interest margin widened to 4.36% from 3.88%.
-
Nine-Month Charge-Offs Hit $50.0M
Net charge-offs were $50.0 million for the nine months ended September 30, 2026 versus $3.7 million a year earlier, tied to previously reserved CRE and non-core C&I relationships.
-
Allowance Cut to $64.2M
The ACL fell to $64.2 million, or 0.85% of total loans, from $97.1 million (1.43%) at December 31, 2025, reflecting the Q1 estimation-process change, charge-offs and a new DCF model; coverage of non-performing loans dropped to 89.5% from 111.7%.
-
Non-Performing Loans Down to $71.7M
Non-performing loans declined to $71.7 million (0.95% of total loans) from $86.9 million (1.28%) at year-end 2025.
Analysis · MCB · Finance
The headline numbers were already out on October 20, but the full 10-Q fills in the credit story behind them. Net charge-offs ran $50.0 million for the first nine months of 2026 versus $3.7 million a year earlier, driven by the CRE and non-core C&I relationships the company had already reserved against. That cleanup, plus a Q1 change in the CECL estimation process and a new discounted-cash-flow model adopted this quarter, pulled the allowance down to $64.2 million, or 0.85% of loans, from $97.1 million (1.43%) at year-end. Non-performing loans also fell to $71.7 million from $86.9 million, so coverage of bad loans now sits at 89.5% versus 111.7% — thinner, but against a smaller problem pool. Capital remains solid: CET1 at 12.8% for the holding company, and the Second Circuit affirmed dismissal of the Voyager lawsuit on October 9, removing a legal overhang.
How filings like this one have moved
In the 30 days to Nov 8, 2026, 36.5% of the 3015 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MCB was trading at $95.47 on NYSE in the Finance sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $64.66 to $102.04. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.